These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 17684611)

  • 21. [Statins and asthma].
    Pawlak J; Ziętkowski Z; Bodzenta-Łukaszyk A
    Postepy Hig Med Dosw (Online); 2011 Mar; 65():177-89. PubMed ID: 21502694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Do the pleiotropic effects of statins have a clinical significance?].
    Vergès B
    Arch Mal Coeur Vaiss; 2004 Dec; 97(12):1231-5. PubMed ID: 15669365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Statin therapy-evidence beyond lipid lowering contributing to plaque stability.
    de Lorenzo F; Feher M; Martin J; Collot-Teixeira S; Dotsenko O; McGregor JL
    Curr Med Chem; 2006; 13(28):3385-93. PubMed ID: 17168712
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The beneficial effects of statins in autoimmune disease therapy.
    Marai I; Shoenfeld Y
    Drug News Perspect; 2007 Apr; 20(3):165-9. PubMed ID: 17520093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Statins reduce vascular inflammation in atherogenesis: A review of underlying molecular mechanisms.
    Liberale L; Carbone F; Montecucco F; Sahebkar A
    Int J Biochem Cell Biol; 2020 May; 122():105735. PubMed ID: 32126319
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Usefulness of statins in protecting against ventricular arrhythmias.
    Abinader EG
    Am J Cardiol; 2006 Jan; 97(1):153-4. PubMed ID: 16377305
    [No Abstract]   [Full Text] [Related]  

  • 27. Anti-inflammatory effects of statins: clinical evidence and basic mechanisms.
    Jain MK; Ridker PM
    Nat Rev Drug Discov; 2005 Dec; 4(12):977-87. PubMed ID: 16341063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
    Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
    Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study.
    Albert MA; Danielson E; Rifai N; Ridker PM;
    JAMA; 2001 Jul; 286(1):64-70. PubMed ID: 11434828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pleiotropic effects of statins in atherosclerosis and diabetes.
    Bellosta S; Ferri N; Arnaboldi L; Bernini F; Paoletti R; Corsini A
    Diabetes Care; 2000 Apr; 23 Suppl 2():B72-8. PubMed ID: 10860194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Ni W; Egashira K; Kataoka C; Kitamoto S; Koyanagi M; Inoue S; Takeshita A
    Circ Res; 2001 Aug; 89(5):415-21. PubMed ID: 11532902
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inflammation as a cardiovascular risk factor.
    Willerson JT; Ridker PM
    Circulation; 2004 Jun; 109(21 Suppl 1):II2-10. PubMed ID: 15173056
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inflammation and beyond: new directions and emerging drugs for treating atherosclerosis.
    Bertrand MJ; Tardif JC
    Expert Opin Emerg Drugs; 2017 Mar; 22(1):1-26. PubMed ID: 27927063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Statin therapy in rheumatoid arthritis.
    Costenbader KH; Coblyn JS
    South Med J; 2005 May; 98(5):534-40; quiz 541, 572. PubMed ID: 15954510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease: C-reactive protein and the inflammatory disease paradigm: HMG-CoA reductase inhibitors, alpha-tocopherol, red yeast rice, and olive oil polyphenols. A review of the literature.
    Patrick L; Uzick M
    Altern Med Rev; 2001 Jun; 6(3):248-71. PubMed ID: 11410071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins: potential new indications in inflammatory conditions.
    Endres M
    Atheroscler Suppl; 2006 Apr; 7(1):31-5. PubMed ID: 16503422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Direct anti-inflammatory mechanisms contribute to attenuation of experimental allograft arteriosclerosis by statins.
    Shimizu K; Aikawa M; Takayama K; Libby P; Mitchell RN
    Circulation; 2003 Oct; 108(17):2113-20. PubMed ID: 14517172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of statins on C-reactive protein and interleukin-6 (the Ludwigshafen Risk and Cardiovascular Health study).
    März W; Winkler K; Nauck M; Böhm BO; Winkelmann BR
    Am J Cardiol; 2003 Aug; 92(3):305-8. PubMed ID: 12888140
    [TBL] [Abstract][Full Text] [Related]  

  • 39. To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.
    Lopez-Pedrera C; Ruiz-Limon P; Valverde-Estepa A; Barbarroja N; Rodriguez-Ariza A
    Curr Drug Targets; 2012 Jun; 13(6):829-41. PubMed ID: 22250652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beyond the laboratory: clinical implications for statin pleiotropy.
    Halcox JP; Deanfield JE
    Circulation; 2004 Jun; 109(21 Suppl 1):II42-8. PubMed ID: 15173062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.